FREDUN PHARMACEUTICALS
|
FREDUN PHARMACEUTICALS Last 5 Year Balance Sheet History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹4.70 Cr | ₹4.53 Cr | ₹4.43 Cr | ₹3.99 Cr | ₹3.99 Cr |
Equity - Authorised | ₹10.00 Cr | ₹10.00 Cr | ₹10.00 Cr | ₹10.00 Cr | ₹10.00 Cr |
Equity - Issued | ₹4.70 Cr | ₹4.53 Cr | ₹4.43 Cr | ₹3.99 Cr | ₹3.99 Cr |
Equity Paid Up | ₹4.70 Cr | ₹4.53 Cr | ₹4.43 Cr | ₹3.99 Cr | ₹3.99 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
Share Warrants & Outstandings | ₹1.57 Cr | ₹8.33 Cr | ₹0.21 Cr | - | - |
Total Reserves | ₹115 Cr | ₹84 Cr | ₹63 Cr | ₹39 Cr | ₹37 Cr |
Securities Premium | ₹71 Cr | ₹55 Cr | ₹45 Cr | ₹27 Cr | ₹27 Cr |
Capital Reserves | - | - | - | - | - |
Profit & Loss Account Balance | ₹44 Cr | ₹29 Cr | ₹18 Cr | ₹12 Cr | ₹10 Cr |
General Reserves | - | - | - | - | - |
Other Reserves | - | - | - | - | - |
Reserve excluding Revaluation Reserve | ₹115 Cr | ₹84 Cr | ₹63 Cr | ₹39 Cr | ₹37 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹121 Cr | ₹96 Cr | ₹68 Cr | ₹43 Cr | ₹41 Cr |
Minority Interest | - | - | - | - | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹13 Cr | ₹15 Cr | ₹42 Cr | ₹29 Cr | ₹11 Cr |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | ₹9.25 Cr | ₹13 Cr | ₹42 Cr | ₹29 Cr | ₹11 Cr |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | ₹3.55 Cr | ₹2.82 Cr | - | - | - |
Unsecured Loans | - | - | - | - | - |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹4.14 Cr | ₹3.84 Cr | ₹1.43 Cr | ₹1.38 Cr | ₹0.94 Cr |
Deferred Tax Assets | - | - | - | - | - |
Deferred Tax Liability | ₹4.14 Cr | ₹3.84 Cr | ₹1.43 Cr | ₹1.38 Cr | ₹0.94 Cr |
Other Long Term Liabilities | - | - | - | - | - |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹2.37 Cr | ₹1.96 Cr | ₹1.71 Cr | ₹1.61 Cr | ₹1.63 Cr |
Total Non-Current Liabilities | ₹19 Cr | ₹21 Cr | ₹45 Cr | ₹32 Cr | ₹14 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹63 Cr | ₹59 Cr | ₹49 Cr | ₹60 Cr | ₹46 Cr |
Sundry Creditors | ₹63 Cr | ₹59 Cr | ₹49 Cr | ₹60 Cr | ₹46 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹12 Cr | ₹8.32 Cr | ₹12 Cr | ₹15 Cr | ₹14 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹1.69 Cr | ₹1.13 Cr | ₹0.91 Cr | ₹5.14 Cr | ₹6.28 Cr |
Interest Accrued But Not Due | - | - | - | - | - |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹9.89 Cr | ₹7.19 Cr | ₹11 Cr | ₹9.70 Cr | ₹7.51 Cr |
Short Term Borrowings | ₹87 Cr | ₹68 Cr | ₹11 Cr | ₹11 Cr | ₹23 Cr |
Secured ST Loans repayable on Demands | ₹80 Cr | ₹64 Cr | ₹3.19 Cr | ₹7.57 Cr | ₹20 Cr |
Working Capital Loans- Sec | ₹80 Cr | ₹64 Cr | ₹3.19 Cr | ₹7.57 Cr | ₹20 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹-74 Cr | ₹-61 Cr | ₹4.36 Cr | ₹-4.61 Cr | ₹-16 Cr |
Short Term Provisions | ₹5.54 Cr | ₹4.29 Cr | ₹2.79 Cr | ₹1.13 Cr | ₹2.57 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹5.54 Cr | ₹4.29 Cr | ₹2.79 Cr | ₹1.13 Cr | ₹2.57 Cr |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | - | - | - | - | - |
Total Current Liabilities | ₹167 Cr | ₹140 Cr | ₹74 Cr | ₹86 Cr | ₹86 Cr |
Total Liabilities | ₹308 Cr | ₹257 Cr | ₹187 Cr | ₹162 Cr | ₹141 Cr |
ASSETS | |||||
Gross Block | ₹63 Cr | ₹52 Cr | ₹42 Cr | ₹38 Cr | ₹37 Cr |
Less: Accumulated Depreciation | ₹16 Cr | ₹13 Cr | ₹9.80 Cr | ₹7.64 Cr | ₹5.64 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹47 Cr | ₹39 Cr | ₹32 Cr | ₹30 Cr | ₹31 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | - | - | - | - | - |
Non Current Investments | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr |
Long Term Investment | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr |
Quoted | - | - | - | - | - |
Unquoted | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr |
Long Term Loans & Advances | ₹3.36 Cr | ₹2.13 Cr | ₹2.00 Cr | ₹1.18 Cr | ₹1.08 Cr |
Other Non Current Assets | ₹0.46 Cr | - | - | - | - |
Total Non-Current Assets | ₹50 Cr | ₹41 Cr | ₹34 Cr | ₹32 Cr | ₹32 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | ₹0.81 Cr | ₹0.31 Cr | ₹0.06 Cr | ₹0.06 Cr | ₹0.05 Cr |
Quoted | - | - | - | - | - |
Unquoted | ₹0.81 Cr | ₹0.31 Cr | ₹0.06 Cr | ₹0.06 Cr | ₹0.05 Cr |
Inventories | ₹175 Cr | ₹150 Cr | ₹46 Cr | ₹68 Cr | ₹50 Cr |
Raw Materials | ₹81 Cr | ₹64 Cr | ₹21 Cr | ₹36 Cr | ₹24 Cr |
Work-in Progress | ₹57 Cr | ₹38 Cr | ₹13 Cr | ₹7.50 Cr | ₹9.28 Cr |
Finished Goods | ₹20 Cr | ₹15 Cr | ₹3.27 Cr | ₹8.49 Cr | ₹7.89 Cr |
Packing Materials | ₹18 Cr | ₹32 Cr | ₹9.07 Cr | ₹15 Cr | ₹9.17 Cr |
Stores  and Spare | - | - | - | - | - |
Other Inventory | - | - | - | - | - |
Sundry Debtors | ₹65 Cr | ₹35 Cr | ₹90 Cr | ₹41 Cr | ₹39 Cr |
Debtors more than Six months | ₹12 Cr | ₹14 Cr | ₹6.95 Cr | ₹2.07 Cr | - |
Debtors Others | ₹53 Cr | ₹21 Cr | ₹83 Cr | ₹39 Cr | ₹39 Cr |
Cash and Bank | ₹1.35 Cr | ₹3.44 Cr | ₹2.07 Cr | ₹1.13 Cr | ₹3.06 Cr |
Cash in hand | ₹0.44 Cr | ₹0.50 Cr | ₹0.55 Cr | ₹0.38 Cr | ₹1.77 Cr |
Balances at Bank | ₹0.91 Cr | ₹2.94 Cr | ₹1.53 Cr | ₹0.75 Cr | ₹1.29 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹1.44 Cr | ₹0.75 Cr | ₹0.58 Cr | ₹0.36 Cr | ₹0.29 Cr |
Interest accrued on Investments | - | - | - | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | - | - | - | - | - |
Other current_assets | ₹1.44 Cr | ₹0.75 Cr | ₹0.58 Cr | ₹0.36 Cr | ₹0.29 Cr |
Short Term Loans and Advances | ₹14 Cr | ₹27 Cr | ₹13 Cr | ₹20 Cr | ₹16 Cr |
Advances recoverable in cash or in kind | ₹3.40 Cr | ₹13 Cr | ₹0.76 Cr | ₹0.79 Cr | ₹2.04 Cr |
Advance income tax and TDS | - | - | - | - | - |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹10 Cr | ₹15 Cr | ₹12 Cr | ₹19 Cr | ₹14 Cr |
Total Current Assets | ₹257 Cr | ₹216 Cr | ₹153 Cr | ₹130 Cr | ₹109 Cr |
Net Current Assets (Including Current Investments) | ₹90 Cr | ₹77 Cr | ₹79 Cr | ₹44 Cr | ₹23 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹308 Cr | ₹257 Cr | ₹187 Cr | ₹162 Cr | ₹141 Cr |
Contingent Liabilities | - | - | - | - | - |
Total Debt | ₹106 Cr | ₹87 Cr | ₹53 Cr | ₹40 Cr | ₹35 Cr |
Book Value | - | 194.27 | 153.07 | 107.96 | 103.57 |
Adjusted Book Value | 255.15 | 194.27 | 153.07 | 107.96 | 103.57 |
Compare Balance Sheet of peers of FREDUN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
FREDUN PHARMACEUTICALS | ₹352.3 Cr | 0.6% | 11.6% | -14.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹433,920.0 Cr | -0.1% | 1.7% | 45.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹155,160.0 Cr | -0.1% | -2.2% | 56.9% | Stock Analytics | |
CIPLA | ₹118,917.0 Cr | 1.7% | 0.5% | 23.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,017.0 Cr | 5.7% | 12.4% | 18.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,997.1 Cr | -1.4% | 3.1% | 44.8% | Stock Analytics |
FREDUN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
FREDUN PHARMACEUTICALS | 0.6% |
11.6% |
-14.3% |
SENSEX | -5% |
0.6% |
9.2% |
You may also like the below Video Courses